Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Defibrotide sodium by Jazz Pharmaceuticals for Sickle Cell Disease: Likelihood of Approval
Defibrotide sodium is under clinical development by Jazz Pharmaceuticals and currently in Phase II for Sickle Cell Disease. According to...
Defibrotide sodium by Jazz Pharmaceuticals for Coronavirus Disease 2019 (COVID-19) Associated Acute Respiratory Distress Syndrome: Likelihood of Approval
Defibrotide sodium is under clinical development by Jazz Pharmaceuticals and currently in Phase I for Coronavirus Disease 2019 (COVID-19) Associated...
Defibrotide sodium by Jazz Pharmaceuticals for Coronavirus Disease 2019 (COVID-19) Pneumonia: Likelihood of Approval
Defibrotide sodium is under clinical development by Jazz Pharmaceuticals and currently in Phase I for Coronavirus Disease 2019 (COVID-19) Pneumonia....